Company Overview of Nuron Biotech Inc.
Nuron Biotech Inc. develops specialty biologics and vaccines. Its product pipeline comprises central nervous system products, such as NU100, a recombinant human interferon beta-1b for the treatment of relapsing remitting multiple sclerosis; wound healing products, including NU200, a recombinant human epidermal growth factor product for healing diabetic foot ulcers and burns; and HibTITER, a conjugate vaccine. The company was founded in 2010 and is based in Exton, Pennsylvania.
1 East Uwchlan Avenue
Exton, PA 19341
Founded in 2010
Key Executives for Nuron Biotech Inc.
Nuron Biotech Inc. Key Developments
Similar Private Companies By Industry
|Keltman Pharmaceuticals, Inc.||United States|
|LC Sciences, LLC||United States|
|Exponential Biotherapies, Inc.||United States|
|Makefield Therapeutics Inc.||United States|
|Vectoris Pharma LLC||United States|
Recent Private Companies Transactions
January 31, 2014
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Fredericksburg, VA | AstellasPosted: Mar 07
- Princeton, NJ | RGPPosted: Mar 05
- Fresno, CA | AstellasPosted: Feb 20
- Missouri | AstellasPosted: Feb 21
Sponsored Financial Commentaries
To contact Nuron Biotech Inc., please visit www.nuronbiotech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.